(Ivanhoe Newswire) --- Obstructive sleep apnea, or OSA, affects nearly a billion ... Finally, there may be another option for Roger — a drug called tirzepatide, also known as Mounjaro or Zepbound.

Medical research continues to advance sleep apnea treatment options. The recent FDA approval of tirzepatide for treating sleep apnea in adults with obesity represents a significant development in ...

Obesity is a common health problem affecting a considerable (and growing) proportion of adult populations worldwide.1 Although overweight and obesity are usually diagnosed by anthropometry, such as ...

The article covers expert-backed comfort tips for CPAP users, alternative treatments and combining therapy solutions for ...

The GLP-1 drug tirzepatide (Zepbound) was recently approved for obstructive sleep apnea in people who are obese, in combination with a healthy diet and physical activity. GLP-1 agonists are quite ...

The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.

While reports of vision problems in patients taking semaglutide and tirzepatide are rare ... treatment for moderate to severe obstructive sleep apnea in obese adults. The study’s authors ...

D.K. ANSWER: Weight loss is effective at treating sleep apnea in many people. However, losing and keeping the weight off in the long-term is very hard for most people. The GLP-1 drug tirzepatide ...

The FDA has approved Zepbound (tirzepatide), a prescription medicine for adults with moderate to severe obstructive sleep apnea and obesity, Eli Lilly and Company announced ina press release.

D.K. ANSWER: Weight loss is effective at treating sleep apnea in many people. However, losing and keeping the weight off in the long-term is very hard for most people. The GLP-1 drug tirzepatide ...